Showing results (1-10 of 696) with videos related to
Sort By:
Pageof 70
Biochemistry|August 7, 1998
Homology model for oncostatin M based on NMR structural dataD Kitchen, R C Hoffman, F J Moy, et al.Biochemistry|April 22, 1997
Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factorF J Moy, M Safran, A P Seddon, et al.Journal of Molecular Biology|June 23, 2001
Solution structure of human IL-13 and implication for receptor bindingF J Moy, E Diblasio, J Wilhelm, et al.Biochemistry|August 5, 2000
Solution structure of ZipA, a crucial component of Escherichia coli cell divisionF J Moy, E Glasfeld, L Mosyak, et al.Biochemistry|October 22, 1996
High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopyF J Moy, A P Seddon, P Böhlen, et al.Journal of Biomolecular NMR|November 1, 1995
1H, 15N, 13C and 13CO assignments and secondary structure determination of basic fibroblast growth factor using 3D heteronuclear NMR spectroscopyF J Moy, A P Seddon, E B Campbell, et al.Journal of Biomolecular NMR|June 1, 1996
Resonance assignments for Oncostatin M, a 24-kDa alpha-helical proteinR C Hoffman, F J Moy, V Price, et al.The Journal of Biological Chemistry|May 29, 2000
Analysis by NMR spectroscopy of the structural homology between the linear and the cyclic peptide recognized by anti-human leukocyte antigen class I monoclonal antibody TP25.99*F J Moy, S A Desai, X Wang, et al.Biochemistry|March 4, 1998
High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMRF J Moy, P K Chanda, S Cosmi, et al.Analytical Chemistry|February 24, 2001
MS/NMR: a structure-based approach for discovering protein ligands and for drug design by coupling size exclusion chromatography, mass spectrometry, and nuclear magnetic resonance spectroscopyF J Moy, K Haraki, D Mobilio, et al.Pageof 70